Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.33 |
| ▸ | PRCP | P42785 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | TDO2 | P48775 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 3/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HTR1D | P28221 | 2/20 | 0.31 |
| ▸ | HTR1B | P28222 | 2/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
| ▸ | PTPRC | P08575 | 1/20 | 0.30 |
| ▸ | PTPRF | P10586 | 1/20 | 0.30 |
| ▸ | CDC25B | P30305 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5331264 | 0.98 | PTGDR2 (0.36) | PTGDR2PRCPIDO1TDO2GAA | |
| SCHEMBL15265880 | 0.96 | PTGDR2 (0.30) | PTGDR2 | |
| SCHEMBL28281441 | 0.82 | — | — | |
| SCHEMBL27524770 | 0.76 | PTGDR2 (0.37) | PTGDR2GAATDP1PTPN1KDM4E | |
| Hydrochloric Acid SCHEMBL6890562 | 0.76 | GAA (0.33) | PTGDR2GAATDP1KDM4E | |
| SCHEMBL7164210 | 0.75 | PRCP (0.36) | PTGDR2PRCPIDO1TDO2GAA | |
| Hydrochloric Acid SCHEMBL6889222 | 0.75 | PTGDR2 (0.34) | PTGDR2PRCPGAAPTPN1KDM4E | |
| SCHEMBL27574092 | 0.73 | PTGDR2 (0.34) | PTGDR2IDO1TDO2GAAKDM4E | |
| Hydrochloric Acid SCHEMBL6889660 | 0.71 | PTGDR2 (0.31) | PTGDR2 | |
| Hydrochloric Acid SCHEMBL6893725 | 0.71 | PTGDR2 (0.31) | PTGDR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3378312-B1 | SUSTAINED RELEASE PHEROMONE PREPARATION | SHINETSU CHEMICAL CO (JP) | 2022-03-02 | — | — | EP | disclosed |
| US-20180271088-A1 | SUSTAINED RELEASE PHEROMONE PREPARATION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-09-27 | — | — | US | disclosed |
| EP-3378312-A1 | SUSTAINED RELEASE PHEROMONE PREPARATION | Shin-Etsu Chemical Co., Ltd. (JP) | 2018-09-26 | — | — | EP | disclosed |
| US-5837777-A | CATALYTIC ADDITION POLMERIZATION OF ACRYLATE MONOMER, REACTION WITH OTHER MONOMERS FOR MOLDING MATERIALS | BASF AKTIENGESELLSCHAFT (DE) | 1998-11-17 | — | — | US | disclosed |
| WO-1993007119-A1 | NOVEL ANTIMALARIAL PEROXIDES AND PROCESSES FOR THEIR PRODUCTION AND USE | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 1993-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180271088-A1 | SUSTAINED RELEASE PHEROMONE PREPARATION | AUP1, SHBG, ADH1A | PTGDR2 1213/4885PRCP 3611/4885IDO1 4281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.